NCT00648921View on ClinicalTrials.gov

Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions
Healthy
Interventions
DRUG

Olanzapine Tablets 5 mg

5mg, single dose fasting

DRUG

Zyprexa® Tablets 5 mg

5mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648921 - Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg | Biotech Hunter | Biotech Hunter